Abound Wealth Management’s Collegium Pharmaceutical COLL Stock Holding History

Abound Wealth Management’s Portfolio COLL Stock Details COLL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$109	Sell	3 -1	-25%	-$34	﹤0.01%	1266
2026 Q1	$133	Hold	4	–	–	﹤0.01%	1350
2025 Q4	$186	Hold	4	–	–	﹤0.01%	1209
2025 Q3	$140	Hold	4	–	–	﹤0.01%	1244
2025 Q2	$119	Hold	4	–	–	﹤0.01%	1209
2025 Q1	$120	Sell	4 -1	-20%	-$31	﹤0.01%	1186
2024 Q4	$144	Hold	5	–	–	﹤0.01%	1176
2024 Q3	$194	Sell	5 -2	-29%	-$71	﹤0.01%	1182
2024 Q2	$226	Sell	7 -3	-30%	-$104	﹤0.01%	1073
2024 Q1	$389	Hold	10	–	–	﹤0.01%	1013
2023 Q4	$308	Buy	+10	New	+$250	﹤0.01%	1149

Other funds holding COLL

Assenagon Asset Management

Assenagon Asset Management Senningerberg, Luxembourg $77B AUM 50.57% 1-Year Est. Return

Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return

Eastern Bank Boston, Massachusetts $6.53B AUM 30.05% 1-Year Est. Return

GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return

Spire Wealth Management Mclean, Virginia $3.31B AUM 38.78% 1-Year Est. Return

MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return

JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return